Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma

by Christos Sachpekidis, Hartmut Goldschmidt, Antonia Dimitrakopoulou-Strauss
Published 2019-12-01

Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible

by Monika Engelhardt, K. Martin Kortüm, Hartmut Goldschmidt, Maximilian Merz
Published 2024-02-01

Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a...

by Christos Sachpekidis, Antonia Dimitrakopoulou-Strauss, Stefan Delorme, Hartmut Goldschmidt
Published 2017-12-01

Imaging Features of Multiple Myeloma Extramedullary Lesions in the Liver with 18F-FDG PET/CT, Contrast-Enhanced CT and MRI

by Dimitris Papamichail, Robert Hog, Hartmut Goldschmidt, Antonia Dimitrakopoulou-Strauss
Published 2019-11-01

Novel immunotherapies in multiple myeloma – chances and challenges

by Leo Rasche, Ralph Wäsch, Markus Munder, Hartmut Goldschmidt, Marc S. Raab
Published 2021-07-01

Germline Risk Contribution to Genomic Instability in Multiple Myeloma

by Siegfried Janz, Fenghuang Zhan, Fenghuang Zhan, Fumou Sun, Yan Cheng, Michael Pisano, Michael Pisano, Ye Yang, Ye Yang, Hartmut Goldschmidt, Hartmut Goldschmidt, Parameswaran Hari
Published 2019-05-01

Therapeutic Advances Propelled by Deciphering Tumor Biology and Immunology—Highlights of the 8th Heidelberg Myeloma Workshop

by Raphael Lutz, Mirco Friedrich, Marc Steffen Raab, Niels Weinhold, Hartmut Goldschmidt
Published 2021-08-01

Bone involvement in patients with systemic AL amyloidosis mimics lytic myeloma bone disease

by Stefan O. Schonland, Jochen Hansmann, Gunnhild Mechtersheimer, Hartmut Goldschmidt, Anthony D. Ho, Ute Hegenbart
Published 2008-06-01

Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels

by Pankaj Yadav, Maximilian Merz, Elias K. Mai, Asta Försti, Anna Jauch, Hartmut Goldschmidt, Kari Hemminki
Published 2018-04-01

Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma

by Michael Hahn, Paul Schnitzler, Brunhilde Schweiger, Christina Kunz, Anthony D. Ho, Hartmut Goldschmidt, Michael Schmitt
Published 2015-07-01

Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma

by Lukas John, Lukas John, Kaya Miah, Axel Benner, Elias K. Mai, Katharina Kriegsmann, Michael Hundemer, Dorothee Kaudewitz, Carsten Müller-Tidow, Carsten Müller-Tidow, Karin Jordan, Karin Jordan, Hartmut Goldschmidt, Hartmut Goldschmidt, Marc S. Raab, Marc S. Raab, Nicola Giesen
Published 2023-04-01

Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myeloma.

by Alboukadel Kassambara, Dirk Hose, Jérôme Moreaux, Thierry Rème, Jennifer Torrent, Jean François Rossi, Hartmut Goldschmidt, Bernard Klein
Published 2012-01-01

Can ¹⁸F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?

by Christos Sachpekidis, Annette Kopp-Schneider, Maximilian Merz, Anna Jauch, Marc-Steffen Raab, Hartmut Goldschmidt, Antonia Dimitrakopoulou-Strauss
Published 2020-05-01

Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cells.

by Alboukadel Kassambara, Matthieu Schoenhals, Jérôme Moreaux, Jean-Luc Veyrune, Thierry Rème, Hartmut Goldschmidt, Dirk Hose, Bernard Klein
Published 2013-01-01

Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the Prognosis

by Cyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, Marc S. Raab, Niels Weinhold, Anja Seckinger, Dirk Hose, Anna Jauch, Asta Försti, Asta Försti, Asta Försti, Kari Hemminki, Kari Hemminki, Thomas Hielscher, Manuela Hummel, Manuela Hummel, Georg Lenz, Hartmut Goldschmidt, Hartmut Goldschmidt, Stefanie Huhn
Published 2021-10-01

Prognostic significance of tumor burden assessed by whole-body magnetic resonance imaging in multiple myeloma patients treated with allogeneic stem cell transplantation

by Jennifer Mosebach, Sofia Shah, Stefan Delorme, Thomas Hielscher, Hartmut Goldschmidt, Heinz-Peter Schlemmer, Stefan Schönland, Ute Hegenbart, Jens Hillengass
Published 2018-02-01

Quantitative dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma

by Christos Sachpekidis, Maximilian Merz, Annette Kopp-Schneider, Anna Jauch, Marc-Steffen Raab, Sandra Sauer, Jens Hillengass, Hartmut Goldschmidt, Antonia Dimitrakopoulou-Strauss
Published 2019-09-01

Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wi...

by Martin Granzow, Ute Hegenbart, Katrin Hinderhofer, Dirk Hose, Anja Seckinger, Tilmann Bochtler, Kari Hemminki, Hartmut Goldschmidt, Stefan O. Schönland, Anna Jauch
Published 2017-07-01

Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients

by Seyed Hamidreza Mahmoudpour, Obul Reddy Bandapalli, Miguel Inácio da Silva Filho, Chiara Campo, Kari Hemminki, Hartmut Goldschmidt, Maximilian Merz, Asta Försti
Published 2018-08-01

Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma

by Jens Hillengass, Sofia Ayyaz, Kerstin Kilk, Marc-André Weber, Thomas Hielscher, Rajiv Shah, Dirk Hose, Stefan Delorme, Hartmut Goldschmidt, Kai Neben
Published 2012-11-01